• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 刺突糖蛋白 S1 诱导 BV-2 小胶质细胞神经炎症。

SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia.

机构信息

Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UK.

出版信息

Mol Neurobiol. 2022 Jan;59(1):445-458. doi: 10.1007/s12035-021-02593-6. Epub 2021 Oct 28.

DOI:10.1007/s12035-021-02593-6
PMID:34709564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8551352/
Abstract

In addition to respiratory complications produced by SARS-CoV-2, accumulating evidence suggests that some neurological symptoms are associated with the disease caused by this coronavirus. In this study, we investigated the effects of the SARS-CoV-2 spike protein S1 stimulation on neuroinflammation in BV-2 microglia. Analyses of culture supernatants revealed an increase in the production of TNF-α, IL-6, IL-1β and iNOS/NO. S1 also increased protein levels of phospho-p65 and phospho-IκBα, as well as enhanced DNA binding and transcriptional activity of NF-κB. These effects of the protein were blocked in the presence of BAY11-7082 (1 µM). Exposure of S1 to BV-2 microglia also increased the protein levels of NLRP3 inflammasome and enhanced caspase-1 activity. Increased protein levels of p38 MAPK was observed in BV-2 microglia stimulated with the spike protein S1 (100 ng/ml), an action that was reduced in the presence of SKF 86,002 (1 µM). Results of immunofluorescence microscopy showed an increase in TLR4 protein expression in S1-stimulated BV-2 microglia. Furthermore, pharmacological inhibition with TAK 242 (1 µM) and transfection with TLR4 small interfering RNA resulted in significant reduction in TNF-α and IL-6 production in S1-stimulated BV-2 microglia. These results have provided the first evidence demonstrating S1-induced neuroinflammation in BV-2 microglia. We propose that induction of neuroinflammation by this protein in the microglia is mediated through activation of NF-κB and p38 MAPK, possibly as a result of TLR4 activation. These results contribute to our understanding of some of the mechanisms involved in CNS pathologies of SARS-CoV-2.

摘要

除了由 SARS-CoV-2 引起的呼吸并发症外,越来越多的证据表明,这种冠状病毒引起的疾病与一些神经症状有关。在这项研究中,我们研究了 SARS-CoV-2 刺突蛋白 S1 刺激对 BV-2 小胶质细胞神经炎症的影响。对培养上清液的分析显示,TNF-α、IL-6、IL-1β 和 iNOS/NO 的产生增加。S1 还增加了磷酸化 p65 和磷酸化 IκBα 的蛋白水平,并增强了 NF-κB 的 DNA 结合和转录活性。这些蛋白的作用在存在 BAY11-7082(1 μM)时被阻断。S1 暴露于 BV-2 小胶质细胞也增加了 NLRP3 炎症小体的蛋白水平,并增强了 caspase-1 活性。在受刺突蛋白 S1(100ng/ml)刺激的 BV-2 小胶质细胞中观察到 p38 MAPK 蛋白水平升高,而在存在 SKF 86,002(1 μM)时,该作用降低。免疫荧光显微镜的结果显示,在 S1 刺激的 BV-2 小胶质细胞中 TLR4 蛋白表达增加。此外,用 TAK 242(1 μM)进行药理学抑制和用 TLR4 小干扰 RNA 转染导致 S1 刺激的 BV-2 小胶质细胞中 TNF-α 和 IL-6 产生的显著减少。这些结果首次提供了证据,证明 S1 诱导了 BV-2 小胶质细胞中的神经炎症。我们提出,这种蛋白在小胶质细胞中诱导的神经炎症是通过 NF-κB 和 p38 MAPK 的激活介导的,可能是由于 TLR4 的激活。这些结果有助于我们理解 SARS-CoV-2 引起的中枢神经系统病变的一些机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/993f2b180a80/12035_2021_2593_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/69f9f610271b/12035_2021_2593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/aa2c5c291f77/12035_2021_2593_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/be9bdb3ecf49/12035_2021_2593_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/cf19f3dde9a5/12035_2021_2593_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/6aaa5d1fc108/12035_2021_2593_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/0765d1790c95/12035_2021_2593_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/9b031c368782/12035_2021_2593_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/732e36ed5c00/12035_2021_2593_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/993f2b180a80/12035_2021_2593_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/69f9f610271b/12035_2021_2593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/aa2c5c291f77/12035_2021_2593_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/be9bdb3ecf49/12035_2021_2593_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/cf19f3dde9a5/12035_2021_2593_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/6aaa5d1fc108/12035_2021_2593_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/0765d1790c95/12035_2021_2593_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/9b031c368782/12035_2021_2593_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/732e36ed5c00/12035_2021_2593_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98dd/8786767/993f2b180a80/12035_2021_2593_Fig9_HTML.jpg

相似文献

1
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia.SARS-CoV-2 刺突糖蛋白 S1 诱导 BV-2 小胶质细胞神经炎症。
Mol Neurobiol. 2022 Jan;59(1):445-458. doi: 10.1007/s12035-021-02593-6. Epub 2021 Oct 28.
2
Zanthoxylum zanthoxyloides inhibits lipopolysaccharide- and synthetic hemozoin-induced neuroinflammation in BV-2 microglia: roles of NF-κB transcription factor and NLRP3 inflammasome activation.花椒麻素通过抑制 NF-κB 转录因子和 NLRP3 炎性小体的激活抑制脂多糖和人工血影蛋白诱导的 BV-2 小胶质细胞神经炎症。
J Pharm Pharmacol. 2021 Mar 1;73(1):118-134. doi: 10.1093/jpp/rgaa019.
3
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.新型冠状病毒刺突糖蛋白 S1 重组蛋白诱导人外周血单个核细胞过度细胞因子产生及其地塞米松抑制作用。
Inflammation. 2021 Oct;44(5):1865-1877. doi: 10.1007/s10753-021-01464-5. Epub 2021 Apr 16.
4
N-acetyldopamine dimer inhibits neuroinflammation through the TLR4/NF-κB and NLRP3/Caspase-1 pathways.N-乙酰多巴胺二聚体通过 TLR4/NF-κB 和 NLRP3/Caspase-1 通路抑制神经炎症。
Acta Biochim Biophys Sin (Shanghai). 2022 Aug 25;55(1):23-33. doi: 10.3724/abbs.2022116.
5
Induction of Neuroinflammation and Neurotoxicity by Synthetic Hemozoin.血红素诱导的神经炎症和神经毒性
Cell Mol Neurobiol. 2019 Nov;39(8):1187-1200. doi: 10.1007/s10571-019-00713-4. Epub 2019 Jul 22.
6
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.抗疟药青蒿琥酯通过 Nrf2 依赖性机制抑制 BV2 小胶质细胞中的神经炎症。
Mol Neurobiol. 2016 Nov;53(9):6426-6443. doi: 10.1007/s12035-015-9543-1. Epub 2015 Nov 25.
7
Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling.SARS-CoV-2 的刺突蛋白通过 NLRP3 炎症小体和 NF-κB 信号通路激活心脏成纤维细胞纤维化。
Cells. 2024 Aug 11;13(16):1331. doi: 10.3390/cells13161331.
8
Lutein suppresses inflammatory responses through Nrf2 activation and NF-κB inactivation in lipopolysaccharide-stimulated BV-2 microglia.叶黄素通过激活核因子E2相关因子2(Nrf2)和使脂多糖刺激的BV-2小胶质细胞中的核因子κB(NF-κB)失活来抑制炎症反应。
Mol Nutr Food Res. 2015 Sep;59(9):1663-73. doi: 10.1002/mnfr.201500109. Epub 2015 Jun 23.
9
IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.白细胞介素-1β是一种由活化的小胶质细胞分泌的早期即刻蛋白,它通过p38丝裂原活化蛋白激酶和核因子κB途径在C6星形细胞瘤细胞中诱导诱导型一氧化氮合酶/一氧化氮的产生。
J Neurosci Res. 2006 Oct;84(5):1037-46. doi: 10.1002/jnr.21011.
10
Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells.阿司匹林触发的脂氧素 A4 通过抑制 NF-κB 和 MAPKs 的激活来减轻 LPS 诱导的 BV-2 小胶质细胞的促炎反应。
J Neuroinflammation. 2011 Aug 10;8:95. doi: 10.1186/1742-2094-8-95.

引用本文的文献

1
Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?长期新冠症状和新冠疫苗副作用是否具有共同的病理生理特征和生化途径?
Int J Mol Sci. 2025 Aug 15;26(16):7879. doi: 10.3390/ijms26167879.
2
Anti-neuroinflammatory therapy for non-pulsatile tinnitus in patients with sinus vascular anomalies: preliminary result on two cases.鼻窦血管异常患者非搏动性耳鸣的抗神经炎症治疗:两例初步结果
Front Neurol. 2025 Jul 23;16:1558196. doi: 10.3389/fneur.2025.1558196. eCollection 2025.
3
SARS-CoV-2 viral proteins trigger pain via TLR2/4-MyD88 pathway.

本文引用的文献

1
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.新型冠状病毒刺突糖蛋白 S1 重组蛋白诱导人外周血单个核细胞过度细胞因子产生及其地塞米松抑制作用。
Inflammation. 2021 Oct;44(5):1865-1877. doi: 10.1007/s10753-021-01464-5. Epub 2021 Apr 16.
2
SARS-CoV-2 spike protein interacts with and activates TLR41.严重急性呼吸综合征冠状病毒2刺突蛋白与Toll样受体4相互作用并激活它。
Cell Res. 2021 Jul;31(7):818-820. doi: 10.1038/s41422-021-00495-9. Epub 2021 Mar 19.
3
SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒蛋白通过Toll样受体2/4(TLR2/4)-髓样分化因子88(MyD88)途径引发疼痛。
Front Mol Neurosci. 2025 Jun 16;18:1163636. doi: 10.3389/fnmol.2025.1163636. eCollection 2025.
4
Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection.新型冠状病毒感染中的固有免疫、治疗靶点及单克隆抗体
PeerJ. 2025 Jun 20;13:e19462. doi: 10.7717/peerj.19462. eCollection 2025.
5
SARS-CoV-2 Spike Protein and Long COVID-Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome.严重急性呼吸综合征冠状病毒2刺突蛋白与新冠后综合征——第2部分:了解刺突蛋白与细胞受体相互作用对新冠后综合征病理生理学的影响
Viruses. 2025 Apr 25;17(5):619. doi: 10.3390/v17050619.
6
SARS-CoV-2 Spike Protein and Long COVID-Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome.严重急性呼吸综合征冠状病毒2刺突蛋白与长期新冠——第1部分:刺突蛋白在长期新冠综合征病理生理机制中的影响
Viruses. 2025 Apr 25;17(5):617. doi: 10.3390/v17050617.
7
Cognitive Sequelae of COVID-19: Mechanistic Insights and Therapeutic Approaches.新冠病毒病的认知后遗症:机制洞察与治疗方法
CNS Neurosci Ther. 2025 Mar;31(3):e70348. doi: 10.1111/cns.70348.
8
Nobiletin and Eriodictyol Suppress Release of IL-1β, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia.川陈皮素和圣草酚抑制脂多糖、新冠病毒刺突蛋白及赭曲霉毒素A刺激的人小胶质细胞释放白细胞介素-1β、CXC趋化因子配体8、白细胞介素-6和基质金属蛋白酶-9。
Int J Mol Sci. 2025 Jan 14;26(2):636. doi: 10.3390/ijms26020636.
9
Neuropsychiatric Burden of SARS-CoV-2: A Review of Its Physiopathology, Underlying Mechanisms, and Management Strategies.新型冠状病毒 2 型的神经精神负担:对其病理生理学、潜在机制及管理策略的综述
Viruses. 2024 Nov 21;16(12):1811. doi: 10.3390/v16121811.
10
Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC.揭示严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白对新冠后综合征(PASC)神经系统长期影响的奥秘。
Front Cell Neurosci. 2024 Dec 18;18:1481963. doi: 10.3389/fncel.2024.1481963. eCollection 2024.
严重急性呼吸综合征冠状病毒2型刺突蛋白S1亚基通过Toll样受体4信号通路在小鼠和人类巨噬细胞中诱导促炎反应。
Heliyon. 2021 Feb 2;7(2):e06187. doi: 10.1016/j.heliyon.2021.e06187. eCollection 2021 Feb.
4
NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors.NF-κB 信号转导作为 COVID-19 的药物靶点:IKKβ 抑制剂的潜在作用。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar;394(3):561-567. doi: 10.1007/s00210-020-02035-5. Epub 2021 Jan 4.
5
Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.细胞因子释放综合征:抑制促炎细胞因子可降低 COVID-19 死亡率。
Eur Cytokine Netw. 2020 Sep 1;31(3):81-93. doi: 10.1684/ecn.2020.0451.
6
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications.靶向炎症细胞因子风暴以对抗新冠肺炎相关严重并发症。
Life Sci. 2021 Feb 15;267:118923. doi: 10.1016/j.lfs.2020.118923. Epub 2020 Dec 23.
7
Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19.COVID-19 引发的神经/神经精神症状的细胞机制。
J Med Virol. 2021 Apr;93(4):1983-1998. doi: 10.1002/jmv.26720. Epub 2020 Dec 23.
8
SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.SARS-CoV-2 刺突蛋白通过激活上皮细胞中的血管紧张素 II 受体信号促进 IL-6 转信号。
PLoS Pathog. 2020 Dec 7;16(12):e1009128. doi: 10.1371/journal.ppat.1009128. eCollection 2020 Dec.
9
Neuroinflammation and protein pathology in Parkinson's disease dementia.帕金森病痴呆的神经炎症和蛋白病理。
Acta Neuropathol Commun. 2020 Dec 3;8(1):211. doi: 10.1186/s40478-020-01083-5.
10
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.炎症小体在 SARS-CoV-2 感染时被激活,并与 COVID-19 患者的严重程度相关。
J Exp Med. 2021 Mar 1;218(3). doi: 10.1084/jem.20201707.